Form 4: SAB Biotherapeutics CMO Sells Shares for Tax

SAB Biotherapeutics' Chief Medical Officer, Alexandra Kropotova, disposed of 988 common shares to cover tax obligations related to RSU vesting.

Summary

• Alexandra Kropotova, Chief Medical Officer of SAB Biotherapeutics, Inc. (SABS), reported a transaction on March 24, 2026.
• The transaction involved the disposition of 988 shares of Common Stock.
• These shares were withheld to satisfy tax withholding requirements upon the vesting of the Issuer's restricted stock units (RSUs).
• Following this transaction, Ms. Kropotova beneficially owns 43,296 shares of Common Stock.
• This beneficial ownership includes 34,553 shares of Common Stock and 8,743 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
• Each RSU represents a contingent right to receive one share of Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative transaction related to executive compensation and tax obligations, rather than a discretionary sale or a reflection of company performance.

Positives

• The transaction indicates the vesting of restricted stock units (RSUs), which is a form of compensation for the Chief Medical Officer, reflecting continued employment and equity participation.

Negatives

• The disposition of shares, while for tax purposes, slightly reduces the insider's direct equity holding in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax withholdings on RSU vesting, are common occurrences in publicly traded companies. These events are typically administrative and do not usually reflect a change in the company's operational performance or strategic direction, nor do they indicate a broader industry trend.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine administrative transaction by an insider for tax purposes, not a discretionary sale indicating a change in sentiment.

Key Dates

Keywords

SAB Biotherapeutics, SABS, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Tax Withholding, Alexandra Kropotova, Chief Medical Officer